Study Paves Way to Design Drugs with Multiple Protein Targets

An international research collaboration led by scientists at the University of North Carolina School of Medicine and the University of Dundee, in the UK, has resulted in the development of a way to efficiently and effectively make designer drugs that hit multiple protein targets at once. This accomplishment, described in the Dec. 13, 2012, issue of the journal Nature, may prove invaluable for creating drugs to treat common human diseases such as diabetes, high blood pressure, obesity, cancer, schizophrenia and bi-polar disorder.

These disorders are considered complex diseases because each has a number of genetic and non-genetic influences that determine susceptibility or whether someone will get the disease or not. For more information, click here to read the full release.